Venkataramani, Vivek

Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein

Venkataramani, V., Rossner, C., Iffland, L., Schweyer, S., Tamboli, I. Y., Walter, J., Wirths, O., & Bayer, T. A. (2010) · Journal of Biological Chemistry

Histone Deacetylase Inhibitors ResearchAlzheimer's disease research and treatments

Cited by 133

Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression

Van San, E., Debruyne, A. C., Veeckmans, G., Tyurina, Y. Y., Tyurin, V. A., Zheng, H., Choi, S. M., Augustyns, K., van Loo, G., Michalke, B., et al. (2023) · Cell Death & Differentiation

Multiple Sclerosis Research StudiesFerroptosis and cancer prognosis

Cited by 103

CD31 Expression Determines Redox Status and Chemoresistance in Human Angiosarcomas

Venkataramani, V., Küffer, S., Cheung, K. C. P., Jiang, X., Trümper, L., Wulf, G. G., & Ströbel, P. (2018) · Clinical Cancer Research

Vascular Tumors and AngiosarcomasAngiogenesis and VEGF in Cancer

Cited by 50

Ferroptosis induces detrimental effects in chronic EAE and its implications for progressive MS

Jhelum, P., Zandee, S., Ryan, F., Zarruk, J. G., Michalke, B., Venkataramani, V., Curran, L., Klement, W., Prat, A., & David, S. (2023) · Acta Neuropathologica Communications

Multiple Sclerosis Research StudiesFerroptosis and cancer prognosis

Cited by 49

A crosstalk between hepcidin and IRE/IRP pathways controls ferroportin expression and determines serum iron levels in mice

Charlebois, E., Fillebeen, C., Katsarou, A., Rabinovich, A., Wisniewski, K., Venkataramani, V., Michalke, B., Velentza, A., & Pantopoulos, K. (2022) · eLife

Iron Metabolism and DisordersFerroptosis and cancer prognosis

Cited by 22